Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Endocrine, Metabolic & Immune Disorders Drug Targets|February 27, 2023
Right Ventricular Dysfunction and Exercise Impairment in Patients with Heart Failure, Insulin Resistance, and Diabetes Mellitus: Insights from the T.O.S.CA. Registry (Cardiovascular Diabetology 2022)Domenico Triggiani, Giuseppe LiscoEndocrine, Metabolic & Immune Disorders Drug Targets|January 31, 2023
When Serum C-Peptide Measurement Drives Adequate Diabetes Mellitus Diagnosis and Therapy: A Case ReportGiuseppe Lisco, Sara Volpe, Domenico Triggiani, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|May 3, 2023
Dyslipidemia and Cardiovascular Prevention in the Elderly: A Balance between Benefits and Risks of Statin Treatment in a Specific PopulationVincenzo Fiore, Alessandra Barucca, Sonia Barraco, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|April 3, 2023
Endocrine, Metabolic, and Immune Pathogenesis of Postmenopausal Osteoporosis. Is there a Therapeutic Role in Natural Products?Giuseppe Lisco, Domenico Triggiani, Vito Angelo Giagulli, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|August 29, 2023
Hypothyroidism in Older Adults: A Narrative ReviewVincenzo Fiore, Alessandra Barucca, S Barraco, et al.Journal of Diabetes Research|February 18, 2025
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life StudyAlfredo Vozza, Sara Volpe, Carlo Custodero, et al.Hormones (Athens, Greece)|November 18, 2023
The neurohypophyseal hormone oxytocin and eating behaviors: a narrative reviewMichele Iovino, Tullio Messana, Simonetta Marucci, et al.Nutrients|February 25, 2023
Iodine Deficiency and Iodine Prophylaxis: An Overview and UpdateGiuseppe Lisco, Anna De Tullio, Domenico Triggiani, et al.Nutrients|November 27, 2024
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life StudySara Volpe, Alfredo Vozza, Giuseppe Lisco, et al.Frontiers in Endocrinology|October 2, 2023
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life studySara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.Pageof 2